Diagnostic Center | November 29, 2023
Roche expands hepatitis diagnostics portfolio
Almost 300 million people globally have chronic hepatitis B
Almost 300 million people globally have chronic hepatitis B
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
Moist wound dressing for chronic wound treatment now available in Germany
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Capnopharm’s new CapnoPen is the first PIPAC nebulizer to obtain CE marking under the new MDR regulation 2017/745
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
The use of procalcitonin testing for sepsis management is highest in the US
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Subscribe To Our Newsletter & Stay Updated
